Consistent Biologics Production at Any Scale
Your Antibody. Consistent. At Any Scale.
| EvoNode | Standard | |
|---|---|---|
| Time to scale | 4–6 weeks | 4–8 months |
| Operating cost | 4× lower | — |
| Scalability risk | <1% | 10% |
Based on head-to-head comparison against standard bioreactor scale-up. Full performance data available on request.
We produce it. You ship it. No new infrastructure, no process headaches.
HOW IT WORKS
-
Cell line, expression system, target volume. We scope and confirm the timeline.
-
Produced on EvoNode in Cambridge, MA. pH, DO, and DCO₂ are monitored throughout every run.
-
Protein produced to spec. Run data included. Same conditions for every repeat order.
100% O₂ saturation · Gentle swirl — no shear stress · Consistent from 550mL to 50–100L · No translation required
Run a pilot. See consistent results before you commit.
Hit the IND Window. No Second Runs.
Bispecifics, multispecifics, ADCs — delicate pools that standard platforms can't protect. EvoNode was built for them.
Failed Rapid Tox run = missed IND window. There's no recovering that time.
High-oxygen, low-shear
Gentle swirl + membrane oxygenation. No impeller shear. No aggressive sparging. Fragile pools stay intact.
No process transfer
Same 550mL environment from pool selection to production volume. No equipment switch. No re-validation.
Per-unit visibility
Unique data per 550mL vessel — pH, DO, DCO₂. Know what's happening before it becomes a problem.
4-6 weeks to scale · 75% faster · <1% scalability risk · No revalidation required - from lab to production scale
Accessible Platform
EvoNode instrument + single-use consumables at a fraction of comparable bioreactor platform cost. Runs in your existing lab with minimal footprint.
Application Support
Our scientific team covers bispecific production, Rapid Tox timelines, and transient CHO. We don't walk away after delivery.
See what EvoNode does for your Rapid Tox workflow.
Transient Expression That Actually Scales.
Transient protein expression has never scaled reliably. EvoNode changes that.
Your flask workarounds hold — until the volume changes, the molecule gets harder, or the client needs it faster.
| EvoNode | Traditional Flask | |
|---|---|---|
| Cell growth (3-day CHO) | 2× | Baseline |
| O₂ saturation | 100% | 85% |
| mAb per cell | Equal | Equal |
Equal mAb per cell — yield preserved, quality intact. Full performance data available on request.
Accessible economics
Significantly lower instrument and operating costs than comparable platforms. Purpose-built for CRO unit economics.
Minimal infrastructure
Small footprint. Runs in existing lab space. One scientist to operate. Operational in weeks.
New revenue capability
Consistent transient expression becomes a differentiator in your service menu — not an asterisk.
Lab scale to production — consistent results · Multiple CHO cell lines · Zero Process Transfer required
Test it on your transient expression process.
Ready to Scale Smarter?
Consistent biologics production without the infrastructure, capital commitment, or wait. Whether you run it or we do—results in weeks, not months.